Trademark Overview
On Monday, June 27, 2005, a trademark application was filed for ENDOREV with the United States Patent and Trademark Office. The USPTO has given the ENDOREV trademark a serial number of 78658820. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, July 15, 2005. This trademark is owned by Glaxo Group Limited. The ENDOREV trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines